Interventions for valvular disease and heart failure
Incidence and clinical impact of infective endocarditis after transcatheter aortic valve implantation
EuroIntervention 2016;11:1180-1187 published online ahead of print February 2015. DOI: 10.4244/EIJY15M02_05
Manuel Martínez-Sellés1,2*, MD, PhD; Emilio Bouza1, MD, PhD; Pablo Díez-Villanueva1, MD, PhD; Maricela Valerio1, MD; María Carmen Fariñas3, MD, PhD; Antonio J. Muñoz-García4, MD, PhD; Josefa Ruiz-Morales4, MD; Juan Gálvez-Acebal5, MD; Isabel Antorrena6, MD; Jesús María de la Hera Galarza7, MD; Enrique Navas8, MD, PhD; Patricia Muñoz1, MD, PhD; on behalf of the GAMES study group
1. Hospital General Universitario Gregorio Marañón, Madrid, Spain; 2. Universidad Europea, Madrid, Spain; 3. Hospital Universitario Marqués de Valdecilla, Santander, Spain; 4. Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain; 5. Hospita
Aims: To describe the characteristics of infective endocarditis (IE) after transcatheter aortic valve implantation (TAVI).